CAS: 1346704-33-3 - GSK 343

Fórmula: C₃₁H₃₉N₇O₂

InChI: InChI=1S/C31H39N7O2/c1-6-7-23-14-21(4)35-31(40)26(23)18-33-30(39)25-15-24(16-28-27(25)19-34-38(28)20(2)3)22-8-9-32-29(17-22)37-12-10-36(5)11-13-37/h8-9,14-17,19-20H,6-7,10-13,18H2,1-5H3,(H,33,39)(H,35,40)

Chave InChI: InChIKey=ULNXAWLQFZMIHX-UHFFFAOYSA-N

SMILES: O=C(NCC=1C(=O)NC(=CC1CCC)C)C2=CC(=CC3=C2C=NN3C(C)C)C=4C=CN=C(C4)N5CCN(C)CC5

Sinónimos:

• 1-(1-Methylethyl)-N-[(6-methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)methyl]-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide
• 1H-Indazole-4-carboxamide, N-[(1,2-dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-
• Gsk 343
• N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide

GSK 343

CAS: 1346704-33-3

• Fórmula: C₃₁H₃₉N₇O₂
• Pureza: 98%
• Cor e Forma: Solid
• Peso molecular: 541.6871

GSK343

CAS: 1346704-33-3

GSK343, a specific and effective EZH2 inhibitor (IC50=4 nM), exhibits 60 fold specificity activity against …

• Fórmula: C₃₁H₃₉N₇O₂
• Pureza: 98% - 99.9%
• Cor e Forma: Solid
• Peso molecular: 541.69

GSK343

CAS: 1346704-33-3

GSK343 is a compound that inhibits the activity of histone methyltransferases. It is used in …

• Fórmula: C₃₁H₃₉N₇O₂
• Pureza: Min. 95%
• Peso molecular: 541.7 g/mol